RemeGen Co., Ltd.
REGMF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,883 | $15,705 | $51,189 | $48,395 |
| - Cash | $760 | $709 | $2,069 | $1,757 |
| + Debt | $2,671 | $1,260 | $165 | $103 |
| Enterprise Value | $7,794 | $16,256 | $49,285 | $46,741 |
| Revenue | $1,710 | $1,076 | $768 | $1,424 |
| % Growth | 58.9% | 40.2% | -46.1% | – |
| Gross Profit | $1,367 | $823 | $498 | $1,357 |
| % Margin | 80% | 76.5% | 64.8% | 95.3% |
| EBITDA | -$1,095 | -$1,248 | -$806 | $402 |
| % Margin | -64.1% | -116% | -104.9% | 28.2% |
| Net Income | -$1,468 | -$1,511 | -$999 | $276 |
| % Margin | -85.9% | -140.4% | -130.1% | 19.4% |
| EPS Diluted | -2.73 | -2.8 | -1.88 | 0.57 |
| % Growth | 2.5% | -48.9% | -429.8% | – |
| Operating Cash Flow | -$1,177 | -$1,502 | -$1,264 | $264 |
| Capital Expenditures | -$265 | -$853 | -$758 | -$617 |
| Free Cash Flow | -$1,442 | -$2,355 | -$2,021 | -$354 |